GLASS of the foot: is the pedal arch modifier a useful tool or a confounding factor?
Angiologia e Cirurgia Vascular · 2026 · 22 (2)
DOI: 10.48750/acv.692 ↗Kurz gefasst
Fachartikel in der Zeitschrift Angiologia e Cirurgia Vascular, 2026. Verfasst von Beatriz Guimarães und 8 weiteren Autor:innen.
Abstract (Originalsprache)
Introduction
The Global Limb Anatomic Staging System (GLASS) has become a widely adopted tool for guiding treatment planning and prediction of revascularization success in chronic limb-threatening ischemia (CLTI). However, the proposed pedal modifier was not included in the initial validation studies and information on its value as an adjunct of the classification remains scarce. Our aim was to evaluate the pedal modifier as a predictor for wound healing and major adverse limb events (MALE) after primary endovascular CLTI revascularization.
Methods
We conducted a retrospective analysis of patients who underwent their first endovascular revascularization for CLTI at a tertiary center between 2020 and 2021. Patients with no available diagnostic angiography were excluded. Electronic medical records were reviewed and angiographic imaging was used to classify each procedure according to their GLASS score including the pedal modifier. Adverse limb events were documented at 30-days, 3, 6 and 12 months.
Results
A total of 118 patients were included in the study. Most patients (83.1%) presented with Rutherford 5 chronic limb ischemia and evenly distributed GLASS severity score (I 15.3%, II 40.7%, III 43.2%). Concerning pedal arch anatomy, 91.5% had at least one artery crossing the ankle to the foot with varying degrees of arch disease-burden. A fully intact arch with minimal disease (P0) was observed in 32.2% of cases, while 53.4% had a diseased or absent arch (P1). Only 14.4% of patients had no named artery crossing the ankle (P2). The median follow-up was 12 months (IQR 6) with a MALE incidence of 34.9% (9.3% major amputation, 33.9% reintervention due to primary revascularization failure). Fifty-seven percent (61%) of patients achieved adequate wound healing during follow-up. After stratification based on the pedal modifier, the three groups (P0, P1 and P2) were comparable concerning demographic and clinical variables. The outcome-related variables did not show any significant difference either isolated or on a sub-analysis after grouping for pedal GLASS severity.
Discussion
Despite growing recognition of the role of anatomic disease burden in CLTI management, the predictive value of the GLASS pedal modifier remains unclear. Our findings suggest that pedal arch patency may not significantly influence revascularization success or amputation-free survival and confirmation of our results in a large data multicentric studies could lead to a paradigm shift.
Schlagwörter
Zitieren
APA
Guimarães, B., Fernandes, L., Machado, M., Basílio, F., Carvalho, P., Rocha, A. M., Martins, V., Coelho, A. P., & Canedo, A. (2026). GLASS of the foot: is the pedal arch modifier a useful tool or a confounding factor?. Angiologia e Cirurgia Vascular, 22(2). https://doi.org/10.48750/acv.692
Vancouver
Guimarães B, Fernandes L, Machado M, Basílio F, Carvalho P, Rocha AM, et al. GLASS of the foot: is the pedal arch modifier a useful tool or a confounding factor?. Angiologia e Cirurgia Vascular. 2026;22(2). doi:10.48750/acv.692
BibTeX
@article{Guimares2026,
author = {Guimarães, Beatriz and Fernandes, Luís and Machado, Marta and Basílio, Francisco and Carvalho, Patrícia and Rocha, Ana Margarida and Martins, Vitor and Coelho, Andreia Pires and Canedo, Alexandra},
title = {GLASS of the foot: is the pedal arch modifier a useful tool or a confounding factor?},
journal = {Angiologia e Cirurgia Vascular},
year = {2026},
volume = {22},
number = {2},
doi = {10.48750/acv.692}
}
EUVIMED